News
-
IP
CRISPR-Cas3 Basic Patent Issued in China (Patent No. ZL 2020 8 0025993.1)
-
Alliance
C4U and Minaris Announce Collaboration in Promotional Activities
-
InformationOther
C4U Secures up to $14M Grant from the Japanese Agency for Medical Research and Development
-
AllianceR&D
Successful Breeding of Euglena utilizing CRISPR-Cas3, a Novel Genome Editing Technology
-
IP
Japan Patent Office Decides to Maintain CRISPR-Cas3 Basic Patent (Patent No. 7430358)
-
IP
Japan Patent Office Decides to Maintain CRISPR-Cas3 Basic Patent (Patent No. 7301332)
-
Alliance
C4U and iXgene execute a collaborative research agreement
-
Information
C4U Selected for the AMED “Project to Promote the Industrialization of Regenerative/CellMedicine and Gene Therapy”
-
Information
C4U and Hiroshima University enter into Collaborative Research Agreement
-
IP
The Patent Issued in India